Advances in digital phenotyping for relapse risk monitoring and community-based treatment and rehabilitation in methamphetamine use disorder

Frontiers in Psychiatry | New and Recent Articles ·
Mind & Mental Health Switzerland

Methamphetamine use disorder (MUD) lacks widely approved pharmacological treatments with consistent efficacy, and community-based care relies largely on psychosocial interventions. Earlier identification of relapse risk in daily life is therefore a practical priority. Digital phenotyping uses smartphones, wearable devices, ecological momentary assessment (EMA), and passive sensing to collect…

Read original article on Frontiers in Psychiatry | New and Recent Articles →

Related news